BioSpace News Archive

AffaMed Therapeutics, a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, announced during the recent “China International Trade in Services Fair 2021" a strategic cooperation partnership with Beijing Tiantan Hospital of Capital Medical University and Beijing Infinite Brain Technologies.

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, announced updated data from its Phase 1 ADP-A2AFP trial for patients with liver cancer at ILCA.

Amgen announced new data from the pivotal NAVIGATOR Phase 3 trial demonstrating that tezepelumab reduced exacerbations and improved lung function and nasal symptoms in patients with severe, uncontrolled asthma and comorbid nasal polyps.

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces that the clinical trial application of ASC42 to treat patients with primary biliary cholangitis has been accepted for review by China National Medical Products Administration.

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company’s stock has been included in the Hong Kong Stock Connect program, effective September 6, 2021.

GeneQuantum Healthcare Co.,Ltd. and BrighGene Biomedical Co.,Ltd. signed a co-development agreement for antibody immune agonist conjugate, GQ1007.